Teslac
Active Ingredient(s): TestolactoneFDA Approved: * June 3, 1969
Pharm Company: * BRISTOL MYERS SQUIBB
Category: Cancer
Testolactone (INN, USAN) (brand name Teslac) is a non-selective, irreversible, steroidal aromatase inhibitor which is used as an antineoplastic drug to treat advanced-stage breast cancer.[1][2][3][4] The drug was discontinued in 2008 and is no longer available for medical use.[4] However, it has been reported to still be marketed in the United States by Bristol-Myers Squibb under the brand name Teslac.[5&a... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.